| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $32,555,208 ) (Continued on the next page) |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | K0149065 | Geriatric Academic Career Awards | 00 | 3 | HRSA | 6/17/2025 | $92,274 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | T9449360 | Advanced Nursing Education Workforce | 00 | 3 | HRSA | 6/16/2025 | $650,000 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01EY032645 | Preclinical evaluation of a homing endonuclease gene therapy for adRP in models of P23H retinopathy. | 000 | 3 | NIH | 4/30/2025 | $574,292 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL168294 | Neuromodulatory rehabilitation for respiratory motor function in individuals with chronic spinal cord injury | 000 | 3 | NIH | 4/25/2025 | $341,585 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | H6500013 | COMMUNITY BASED DENTAL PARTNERSHIP | 00 | 24 | HRSA | 6/17/2025 | $247,424 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL168198 | Role of the PEP cycle in cardiac fibrosis | 000 | 2 | NIH | 11/29/2024 | $523,760 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R21EY034674 | Detailed Molecular Structures of Tear Film Lipid Layer for Improved Treatment of Dry Eye Syndrome | 000 | 2 | NIH | 11/21/2024 | $183,077 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01CA272772 | Identifying and targeting a novel mechanism of chemotherapy-induced immunotherapeutic resistance in non-small cell lung cancer | 001 | 3 | NIH | 5/22/2025 | $35,304 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01CA272772 | Identifying and targeting a novel mechanism of chemotherapy-induced immunotherapeutic resistance in non-small cell lung cancer | 000 | 3 | NIH | 3/20/2025 | $317,740 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL150581 | Epidural spinal cord stimulation and respiratory motor function after injury | 001 | 5 | NIH | 6/26/2025 | $74,615 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL150581 | Epidural spinal cord stimulation and respiratory motor function after injury | 000 | 5 | NIH | 4/18/2025 | $671,527 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01DE030939 | A T.fosythia-derived protease inhibitor in periodontal health and disease | 000 | 4 | NIH | 5/16/2025 | $539,501 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01DK131442 | The role of neutral ceramidase in intestinal fucosylation and liver steatosis and inflammation | 000 | 3 | NIH | 4/16/2025 | $398,430 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | H7600536 | EARLY INTERVENTION SERVICES | 00 | 26 | HRSA | 4/28/2025 | $188,298 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01DC019634 | The fungiform papilla as a multi-sensory end-organ | 000 | 4 | NIH | 6/26/2025 | $402,631 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | UG3NS140971 | Gastric Electrical Stimulation for Pain in Gastroparesis | 000 | 1 | NIH | 6/9/2025 | $451,297 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01AA028905 | Role of Soluble Epoxide Hydrolase in Alcohol-Associated Liver Disease | 000 | 4 | NIH | 5/12/2025 | $408,636 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | S10OD038345 | Expansion of Physiology Core: The Vevo F2 High Resolution Preclinical Ultrasound System | 000 | 1 | NIH | 4/24/2025 | $564,650 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01AI148241 | Iron independent role for yersiniabactin in Yersinia pestis | 002 | 5 | NIH | 6/2/2025 | $648,417 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01NS138333 | Cell type-specific effects of the integrated stress response pathway after traumatic spinal cord injury | 000 | 1 | NIH | 5/7/2025 | $591,304 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R21CA292333 | Guadecitabine-directed immune regulation in targeting prostate cancer | 000 | 1 | NIH | 4/7/2025 | $234,889 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01ES027778 | Mechanism for arsenic induced carcinogenesis | 002 | 7 | NIH | 12/5/2024 | $662,892 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01ES027778 | Mechanism for arsenic induced carcinogenesis | 003 | 7 | NIH | 12/17/2024 | $142,292 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01AT008617 | Mechanisms underlying edible exosome-like nanoparticles for prevention of brain inflammation | 000 | 9 | NIH | 6/13/2025 | $583,499 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | P20GM113226 | Hepatobiology and Toxicology COBRE | 000 | 10 | NIH | 5/28/2025 | $2,197,056 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | T35DK072923 | Summer Endocrine Research Training Program | 000 | 20 | NIH | 6/5/2025 | $54,332 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R13AI188931 | Mid-Atlantic Microbial Pathogenesis Meeting | 000 | 1 | NIH | 1/23/2025 | $6,500 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01DE011111 | P. gingivalis interactions with gingival epithelial cells | 002 | 31 | NIH | 4/22/2025 | $826 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | T35ES014559 | Summer Environmental Health Sciences Training Program | 000 | 19 | NIH | 6/4/2025 | $45,177 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01DE011111 | P. gingivalis interactions with gingival epithelial cells | 001 | 31 | NIH | 4/17/2025 | $344,541 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01DE012505 | Molecular Aspects of Oral Plaque Formation | 001 | 28 | NIH | 5/9/2025 | $44,319 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | F31EY034730 | Optimizing c-Met signaling to enhance corneal epithelial homeostasis | 000 | 2 | NIH | 3/20/2025 | $35,822 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R03DE033707 | Cobalamin in Porphyromonas gingivalis Pathogenicity | 001 | 2 | NIH | 5/9/2025 | $15,650 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R03DE033707 | Cobalamin in Porphyromonas gingivalis Pathogenicity | 000 | 2 | NIH | 3/5/2025 | $140,850 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01CA278941 | Understanding Pancreatic Cancer Immune Microenvironment and Treatment Response through Integrating in vivo Imaging with Immunophenotyping | 001 | 2 | NIH | 5/22/2025 | $64,947 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01CA278941 | Understanding Pancreatic Cancer Immune Microenvironment and Treatment Response through Integrating in vivo Imaging with Immunophenotyping | 000 | 2 | NIH | 2/17/2025 | $584,526 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01ES034389 | Role of Splenic Pro-Resolving Mediators During Exposure to Particulate Air Pollution | 000 | 3 | NIH | 3/7/2025 | $568,103 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01DE028883 | Topical Vitamin D and Periodontal Disease | 001 | 5 | NIH | 5/8/2025 | $40,256 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01DE028883 | Topical Vitamin D and Periodontal Disease | 000 | 5 | NIH | 3/7/2025 | $362,313 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R03DE033729 | lluminating the Role of the Novel G Protein-Coupled P2Y10 Receptor in Sjögren’s Disease Pathophysiology | 001 | 2 | NIH | 3/5/2025 | $135,765 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R03DE033729 | lluminating the Role of the Novel G Protein-Coupled P2Y10 Receptor in Sjögren’s Disease Pathophysiology | 003 | 2 | NIH | 4/10/2025 | $105,748 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | P20GM103436 | IDeA Networks of Biomedical Research Excellence in Kentucky | 003 | 25 | NIH | 6/2/2025 | $4,034,092 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL163818 | Systematic identification of cardiotoxic e-cigarette flavorants | 002 | 4 | NIH | 5/3/2025 | $714,300 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R25ES036039 | KEEP: Kentucky Environmental Education Pipeline, A program to retain a diverse and equitable scientific trainee pipeline | 000 | 2 | NIH | 1/6/2025 | $133,521 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01GM144349 | Linking the conformational landscape to enzymatic function through functional site distant mutations | 000 | 4 | NIH | 12/16/2024 | $291,736 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01AI172873 | Neutrophil Heterogeneity and Immunopathogenesis of COVID-19 ARDS | 000 | 3 | NIH | 12/13/2024 | $556,881 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL163003 | Mechanisms Contributing to Pregnancy-induced Cardiac Remodeling | 000 | 3 | NIH | 12/23/2024 | $479,561 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R01HL160927 | Fibroblast growth factor 1 prevents hyperlipidemia and atherosclerosis | 000 | 4 | NIH | 11/20/2024 | $479,176 |
| | 2025 | 2025 | UNIVERSITY OF LOUISVILLE | 2301 S 3RD ST | LOUISVILLE | KY | 40208-1838 | JEFFERSON | USA | R21CA280141 | Lectikines for Immunotherapy against Ovarian Cancer | 001 | 2 | NIH | 6/4/2025 | $21,699 |
|
